- Home
- CVRX vs OMER Comparison
CVRX vs OMER Comparison
Compare CVRX & OMER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVRX
- OMER
- Stock Information
- Founded
- CVRX 2000
- OMER 1994
- Country
- CVRX United States
- OMER United States
- Employees
- CVRX N/A
- OMER N/A
- Industry
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- OMER Biotechnology: Pharmaceutical Preparations
- Sector
- CVRX Health Care
- OMER Health Care
- Exchange
- CVRX Nasdaq
- OMER Nasdaq
- Market Cap
- CVRX 419.8M
- OMER N/A
- IPO Year
- CVRX 2021
- OMER 2009
- Fundamental
- Price
- CVRX $7.78
- OMER $6.31
- Analyst Decision
- CVRX Strong Buy
- OMER Buy
- Analyst Count
- CVRX 6
- OMER 4
- Target Price
- CVRX $17.60
- OMER $22.50
- AVG Volume (30 Days)
- CVRX 315.7K
- OMER 539.1K
- Earning Date
- CVRX 05-08-2025
- OMER 05-19-2025
- Dividend Yield
- CVRX N/A
- OMER N/A
- EPS Growth
- CVRX N/A
- OMER N/A
- EPS
- CVRX N/A
- OMER N/A
- Revenue
- CVRX $51,292,000.00
- OMER N/A
- Revenue This Year
- CVRX $22.17
- OMER N/A
- Revenue Next Year
- CVRX $24.02
- OMER $2,447.88
- P/E Ratio
- CVRX N/A
- OMER N/A
- Revenue Growth
- CVRX 30.53
- OMER N/A
- 52 Week Low
- CVRX $5.81
- OMER $3.00
- 52 Week High
- CVRX $18.55
- OMER $13.60
- Technical
- Relative Strength Index (RSI)
- CVRX 46.08
- OMER 37.39
- Support Level
- CVRX $7.30
- OMER $6.83
- Resistance Level
- CVRX $8.28
- OMER $7.49
- Average True Range (ATR)
- CVRX 0.49
- OMER 0.42
- MACD
- CVRX 0.32
- OMER -0.03
- Stochastic Oscillator
- CVRX 79.76
- OMER 5.56
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.